Literature DB >> 1258359

Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine.

W G Laver, R G Webster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1258359     DOI: 10.1016/0042-6822(76)90481-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  24 in total

Review 1.  Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target.

Authors:  Neetu Singh; Aseem Pandey; Suresh K Mittal
Journal:  Expert Rev Mol Med       Date:  2010-04-29       Impact factor: 5.600

Review 2.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Influenza virus-specific cytotoxic T-cell recognition: stimulation of nucleoprotein-specific clones with intact antigen.

Authors:  D C Wraith; A E Vessey
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

4.  Structure of the membrane protein of influenza virus. I. Isolation and characterization of cyanogen bromide cleavage products.

Authors:  B H Robertson; A S Bhown; R W Compans; J C Bennett
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

5.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

Review 6.  An update on the prevention of influenza in children and adolescents.

Authors:  Ulrich Heininger
Journal:  Eur J Pediatr       Date:  2003-10-21       Impact factor: 3.183

7.  Lymphocyte blastogenic responses to influenza virus antigens after influenza infection and vaccination in humans.

Authors:  R Dolin; B R Murphy; E A Caplan
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

8.  Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus.

Authors:  Victor C Huber; Loren H Kleimeyer; Jonathan A McCullers
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

9.  Comparative immunogenicity of live influenza viruses and their solubilized neuraminidases: results of mouse protection experiments.

Authors:  C Bottex; M F Burckhart; R Fontanges
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

10.  Matrix protein from influenza A virus and its role in cross-protection in mice.

Authors:  R G Webster; V S Hinshaw
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.